Accelerate Diagnostics Inc

$ 22.05
Updated 17/08/2018
Change % 0.00% Stock price unchanged
Change 0.00 Stock price unchanged
Volume 35,539
High $ 22.15
Low $ 21.70
Open $ 21.70
Prev close $ 21.80
# of shares 54.13M
Market cap 1,193.52M USD

Market closed
Accelerate Diagnostics Inc
Market is closed, opens at 14:30
Price development Latest 1 week 1 month 3 months 6 months 1 year
  22.05 -0.9% Stock price decreasing 2.1% Stock price increasing 2.1% Stock price increasing -12.3% Stock price decreasing 1.6% Stock price increasing
Powered by TradingView

News about Accelerate Diagnostics Inc

  • English
  • Regulatory news

Company profile

Accelerate Diagnostics Inc is an in vitro diagnostics company that specializes in rapid diagnostics for infectious pathogens. The firm's core platform, the Accelerate ID/AST System, determines whether live bacterial or fungal cells in a patient sample are susceptible to a particular antibiotic. This test is performed on pathogens that are commonly associated with serious infections and can deliver results more quickly than traditional methods, such as bacterial culturing. The system can analyze a positive blood culture sample in approximately five hours, which is faster than traditional testing techniques.

Copyright Euroinvestor A/S 2018   Disclaimer and Terms of Use
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
18 August 2018 07:13:25
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20180816.1 - EUROWEB2 - 2018-08-18 08:13:25 - 2018-08-18 07:13:25 - 1000 - Website: OKAY